Skip to main content

Table 1 Baseline characteristics of included patients

From: In vivo efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo

 

ASAQ (n = 144)

AL (n = 144)

p value

Age, in months

32.2 (20.0–47.0)

30.9 (21.0–41.5)

0.412

# Male (%)

65 (79)

65 (79)

1.000

Weight for height Z-score

−0.59 (−1.39 to 0.22)

−0.68 (−1.40–0.08)

0.484

Temperature in  °C

38.8 (38.0–39.7)

39.02 (38.4–39.8)

0.049

Parasite density/µl at day 0

63,637 (15, 211–95, 962)

45,154 (14, 225–94, 746)

0.826

Log parasite density at day 0

10.5 (9.6–11.5)

10.4 (9.6–11.5)

0.935

Haemoglobin in g/dl at day 0

9.5 (8.5–10.8)

9.7 (8.7–10.8)

0.316

  1. All data is presented as the mean with the interquartile range (IQR) in brackets, unless otherwise stated